Basic Information
RNALocate ID: | RLID:11004375 |
RNA Symbol: | hsa-miR-320d |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-320d |
RNA ID: | miRBase:MIMAT0006764 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002800 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004369 | Exosome | Pooled sera | 27278097 |
RLID:11004370 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004371 | Exosome | Plasma | 23663360 |
RLID:11004372 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11004373 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11004374 | Microvesicle | Plasma | 23077538 |
RLID-D:11000804 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001744 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-320d | Ovarian clear cell carcinoma | MNDR-E-MI-39497 |
MNDR | hsa-miR-320d | Estrogen-receptor positive breast cancer | MNDR-E-MI-39498 |
MNDR | hsa-miR-320d | Estrogen-receptor negative breast cancer | MNDR-E-MI-39499 |
MNDR | hsa-miR-320d | Progesterone-receptor positive breast cancer | MNDR-E-MI-39500 |
MNDR | hsa-miR-320d | Progesterone-receptor negative breast cancer | MNDR-E-MI-39501 |
MNDR | hsa-miR-320d | Her2-receptor positive breast cancer | MNDR-E-MI-39502 |
MNDR | hsa-miR-320d | Prostate cancer | MNDR-E-MI-39503 |
MNDR | hsa-miR-320d | Gastric cancer | MNDR-E-MI-39504 |
MNDR | hsa-miR-320d | Alzheimer disease | MNDR-E-MI-39505 |
MNDR | hsa-miR-320d | Intracranial aneurysm | MNDR-E-MI-39506 |
MNDR | hsa-miR-320d | Cardiovascular disease | MNDR-E-MI-39507 |
MNDR | hsa-miR-320d | Moyamoya disease | MNDR-E-MI-39508 |
MNDR | hsa-miR-320d | Lung cancer | MNDR-E-MI-39509 |
MNDR | hsa-miR-320d | Parkinson disease | MNDR-E-MI-39510 |
MNDR | hsa-miR-320d | Breast cancer | MNDR-E-MI-39511 |
MNDR | hsa-miR-320d | Pancreatic cancer | MNDR-E-MI-39512 |
MNDR | hsa-miR-320d | Nephroblastoma | MNDR-E-MI-39513 |
MNDR | hsa-miR-320d | Colon cancer | MNDR-E-MI-39514 |
MNDR | hsa-miR-320d | Relapsing-remitting multiple sclerosis | MNDR-E-MI-39515 |
MNDR | hsa-miR-320d | Familial ovarian cancer | MNDR-E-MI-39516 |
MNDR | hsa-miR-320d | Prostate adenocarcinoma | MNDR-E-MI-39517 |
MNDR | hsa-miR-320d | Carcinoma ductal breast | MNDR-E-MI-39518 |
MNDR | hsa-miR-320d | Glioblastoma | MNDR-E-MI-39519 |
MNDR | hsa-mir-320d | Glioma | MNDR-E-MI-39520 |
MNDR | hsa-miR-320d | Chronic obstructive pulmonary disease | MNDR-E-MI-39521 |
MNDR | hsa-miR-320d | Chordoma | MNDR-E-MI-39522 |
MNDR | hsa-miR-320d | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39523 |
MNDR | hsa-miR-320d | Lung squamous cell carcinoma | MNDR-E-MI-39524 |
MNDR | hsa-miR-320d | Non-small cell lung adenocarcinoma | MNDR-E-MI-39525 |
MNDR | hsa-miR-320d | Lung adenocarcinoma | MNDR-E-MI-39526 |
MNDR | hsa-miR-320d | Adrenocortical cancer | MNDR-E-MI-39527 |
MNDR | hsa-miR-320d | Thyroid carcinoma | MNDR-E-MI-39528 |
MNDR | hsa-miR-320d | Pancreatic adenocarcinoma | MNDR-E-MI-39529 |
MNDR | hsa-miR-320d | Myasthenia gravis autoimmune experimental | MNDR-E-MI-39530 |
MNDR | hsa-miR-320d | Kidney renal clear cell carcinoma | MNDR-E-MI-39531 |
MNDR | hsa-miR-320d | Renal clear cell carcinoma | MNDR-E-MI-39532 |
MNDR | hsa-miR-320d | Biliary tract cancer | MNDR-E-MI-39533 |
MNDR | hsa-miR-320d | Head and neck squamous cell carcinoma | MNDR-E-MI-39534 |
MNDR | hsa-miR-320d | Breast invasive carcinoma | MNDR-E-MI-39535 |
MNDR | hsa-miR-320d | Familiar ovarian carcinoma | MNDR-E-MI-39536 |
MNDR | hsa-miR-320d | B-cell lymphoma | MNDR-E-MI-39537 |
MNDR | hsa-miR-320d | Rheumatoid arthritis | MNDR-E-MI-39538 |
MNDR | hsa-miR-320d | Retinoblastoma | MNDR-E-MI-39539 |
MNDR | hsa-miR-320d | Skin cutaneous melanoma | MNDR-E-MI-39540 |
MNDR | hsa-miR-320d | Skin melanoma | MNDR-E-MI-39541 |
MNDR | hsa-miR-320d | Colorectal cancer | MNDR-E-MI-39542 |
MNDR | hsa-miR-320d | Stroke lacunar | MNDR-E-MI-39543 |
MNDR | hsa-miR-320d | Breast cancer her3+ negative | MNDR-E-MI-39544 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABHD13 | Homo sapiens | RR00025355 |
TOP